SOM BIOTECH
 
You are here: Home

Information: At SOM Biotech, every day presents a chance to contribute to innovation. Innovation means to us pushing the frontiers of medicine with the most cutting-edge technologies and processes. The driving force of these actions is the belief that the impossible can be done. Success is not singular. It demands everyone’s participation. We need to put together the enough efforts to find breakthrough therapies for patients in need across the globe. This is the reason why, SOM Biotech works in an Open Innovation space, where all the drug repositioning ideas and challenges are welcome and compensated if a final product is achieved. Do you have a nice repositioning proposal? Please fill and send.

 














Hot News

Repurposing drugs; more than $20Billion in sales
September, 2012

A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.
 
 
SOM Biotech in New European Economy
Winter, 2012

SOM Biotech, has been identified as one of the best opportunities to invest in start-up biopharmaceuticals companies in Catalonia. Link:  http://www.neweuropeaneconomy.com/home-mainmenu-51/fdi-mainmenu-59/514-adding-value-to-existing-drugs
 
SOM0226 presented at the XIIIth International Symposium on Amyloidosis

May 6th-10th, 2012

SOM0226, a reprofiled drug for the treatment of TTR amyloidosis, has been presented at the XIIIth International Symposium on Amyloidosis in Groningen, The Netherlands. The product has been recognized as one of the most promising in-coming therapies by the scientific expert community in the field.

 

BIOINCUBADORA

innova31

logo_biocat_rgb

asebio

Ministerio de Sanidad

CDTI

ENISA

ACC1O

NEWS